logoTry Persana

Persephone Biosciences - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Persephone Biosciences including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Persephone Biosciences company logo

We are a synthetic biology company developing a platform to industrialize and scale the microbiome.

Persephone Biosciences is pioneering the use of synthetic biology for microbial products that impact patient and infant health. The company is building an end-to-end platform to industrialize the development of engineered cells that restore health to damaged human ecosystems.

HeadquartersSan Diego, United States
Team size10-50
Founded2017

What is Persephone Biosciences? - Company Overview & Details

Persephone Biosciences is Persephone Biosciences is pioneering the use of synthetic biology for microbial products that impact patient and infant health. The company is building an end-to-end platform to industrialize the development of engineered cells that restore health to damaged human ecosystems. Founded in 2017, the company is headquartered in San Diego, United States.

Who Founded Persephone Biosciences?

Persephone Biosciences was founded by Stephanie Culler, Steve Van Dien.

Who are the Key Executives at Persephone Biosciences? - Leadership Team

Persephone Biosciences is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Persephone Biosciences

Stephanie CullerCEO

Chief Technology Officer (CTO) of Persephone Biosciences

CTO

About Stephanie Culler - CEO of Persephone Biosciences

Stephanie Culler serves as the Chief Executive Officer of Persephone Biosciences, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Persephone Biosciences Company Details & Key Information

Where is Persephone Biosciences located?

Persephone Biosciences is headquartered in San Diego, United States.

How many employees does Persephone Biosciences have?

Persephone Biosciences has 10-50 employees.

When was Persephone Biosciences founded?

Persephone Biosciences was founded in 2017.

Persephone Biosciences Official Website

How much funding has Persephone Biosciences raised?

Persephone Biosciences has raised $15 Million across 1 funding rounds. The most recent funding was completed on 2022-07-17.

Funding Overview

Persephone Biosciences closed a $15 million seed funding round aimed at advancing its ARGONAUT trial and developing microbiome-based treatments.

$15 Million
Total Funding Raised
1
Funding Rounds
2022-07-17
Latest Round

Persephone Biosciences Funding History

Seed
2022-07-17
$15 Million

Who are the key investors in Persephone Biosciences?

Persephone Biosciences is backed by 3 key investors including First Bight Ventures, Propel Bio Partners, Y Combinator. These investors focus on sectors.

Persephone Biosciences Investor Overview

3
Key Investors
0
Focus Areas
0
Notable Investments

Complete List of Persephone Biosciences Investors

First Bight Ventures

Propel Bio Partners

Y Combinator

What sectors do Persephone Biosciences investors focus on?

The investors backing Persephone Biosciences primarily focus on sectors.

Featured Investor: First Bight Ventures

First Bight Ventures

Notable Investments:

What are Persephone Biosciences's future plans?

Persephone Biosciences Focus on advancing microbiome-based therapeutics and enhance clinical studies.

Persephone Biosciences Strategic Outlook

Strategic Focus
Defined
0
Key Challenges
0
Growth Opportunities

What are the latest news about Persephone Biosciences?

Persephone Biosciences has 2 recent news updates covering key business developments and market activities.

Persephone Biosciences News Overview

2
Recent Articles
Active
Media Coverage
2023-10-23
Latest Update

What is Persephone Biosciences in the news for?

Persephone Biosciences is currently featured in news for Persephone Biosciences Inc. appointed Daniel Bradbury as Chair of the Board of Directors on Oct 23rd '23. and other significant business developments.

Recent News Articles About Persephone Biosciences

Article 1
2023-10-23

Persephone Biosciences Inc. appointed Daniel Bradbury as Chair of the Board of Directors on Oct 23rd '23.

Persephone Biosciences appoints Daniel Bradbury as Chair of the Board of Directors.

yahoo.com
Read News
Article 2
2023-10-19

Persephone Biosciences Inc. launched AMBROSIA on Oct 19th '23.

Persephone Biosciences announces the launch of its Food as Medicine clinical study, AMBROSIA.

biospace.com
Read News

Persephone Biosciences FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Persephone Biosciences including information about founders, CEO, funding history, investors, headquarters location, and company details. 16 frequently asked questions covering key information about the company.

Persephone Biosciences Questions & Answers - Company Information

Q1

What is Persephone Biosciences?

Persephone Biosciences is pioneering the use of synthetic biology for microbial products that impact patient and infant health. The company is building an end-to-end platform to industrialize the development of engineered cells that restore health to damaged human ecosystems.

Q2

Who founded Persephone Biosciences?

Persephone Biosciences was founded by Stephanie Culler, Steve Van Dien.

Q3

Who is the CEO of Persephone Biosciences?

The CEO of Persephone Biosciences is Stephanie Culler. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Persephone Biosciences raised?

Persephone Biosciences has raised a total of $$15 Million across 1 funding rounds. The most recent funding was completed on 2022-07-17.

Q5

Who are the investors in Persephone Biosciences?

Persephone Biosciences's key investors include First Bight Ventures, Propel Bio Partners, Y Combinator.

Q6

Where is Persephone Biosciences headquartered?

Persephone Biosciences is headquartered in San Diego, United States.

Q7

When was Persephone Biosciences founded?

Persephone Biosciences was founded in 2017.

Q8

How many employees does Persephone Biosciences have?

Persephone Biosciences has 10-50 employees.

Q9

What is Persephone Biosciences's official website?

You can visit Persephone Biosciences's official website at http://persephonebiosciences.com.

Q10

What was Persephone Biosciences's latest funding round?

Persephone Biosciences's latest funding round was a Seed round of $$15 Million completed on 2022-07-17.

Q11

Who is founder?

Stephanie Culler

Q12

What does the company do?

Persephone Biosciences develops microbiome-based medicines to improve patient and infant health.

Q13

How much funding?

$15 Million

Q14

Latest funding date?

2022-07-17

Q15

Who are the investors?

First Bight Ventures Propel Bio Partners Y Combinator

Q16

Latest news?

Persephone Biosciences appoints Daniel Bradbury as Chair of the Board of Directors. Persephone Biosciences announces the launch of its Food as Medicine clinical study, AMBROSIA.

More Information About Persephone Biosciences

For additional details about Persephone Biosciences, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.